Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2667
Peer-review started: January 10, 2022
First decision: March 8, 2022
Revised: March 15, 2022
Accepted: May 8, 2022
Article in press: May 8, 2022
Published online: June 28, 2022
Processing time: 164 Days and 14.2 Hours
Core Tip: Proton pump inhibitor (PPI) therapy is a cornerstone therapy for acid-related diseases. Its clinical success can be attributed to anti-secretory properties superior to any prior agents and seemingly low side-effects profile. As more patients were started and continued PPI therapy long-term, some studies began reporting side-effects associated with this therapy. Concerns over risks associated with PPI use grew over the last couple of years among both patients and providers. We hope to bring awareness to the current guidelines and the evidence behind the reported side-effects as better understanding of this evidence can improve medical practice. Both patients and providers should have all the evidence at hand when discussing initiation or continuation of PPI therapy.
